1.

Record Nr.

UNINA9910464892903321

Autore

Bayles Kathryn A. <1942->

Titolo

MCI and Alzheimer's dementia : clinical essentials for assessment and treatment of cognitive-communication disorders / / Kathryn A. Bayles, Cheryl K. Tomoeda ; Kimberly C. McCullough, contributor

Pubbl/distr/stampa

San Diego, California : , : Plural Publishing, Inc., , 2013

©2013

ISBN

1-59756-641-1

Descrizione fisica

1 online resource (xix, 209 pages) : illustrations

Disciplina

616.8/31

Soggetti

Alzheimer's disease - Diagnosis

Alzheimer's disease - Treatment

Mild cognitive impairment - Diagnosis

Mild cognitive impairment - Treatment

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references at the end of each chapters and index.

Nota di contenuto

Contents; Preface; Introduction; Acknowledgments; Contributors; Unit 1: Cognition, Memory, and Communication; Cognition and Memory; The "Company of Cognition"; Memory Defined; Sensory Memory; Working Memory; Long-Term Memory; Relation of Cognition and Memory to Communication; Production of Linguistic Information; Comprehension of Linguistic Information; Summary of Important Points; References; Unit 2: MCI: Minimal Cognitive Impairment; Mild Cognitive Impairment; Clinical Presentations of MCI; Prevalence of MCI in the Population; Diagnostic Criteria for MCI and AD; Conversion to Dementia

Conversion Rate by MCI SubtypeNumber of Deficits and Conversion to Dementia; Risk and Protective Factors; Cognitive Deficits; Cognitive-Linguistic Deficits; Type of Language Changes; Summary; Summary of Important Points; References; Unit 3: Alzheimer's Dementia; Alzheimer's Disease; Diagnostic Criteria for AD; Neuropathology of AD; Risk Factors for AD; Age; Family History of AD; Less Education; History



of Head Trauma; Loneliness; Gender; Maternal Age; Apolipoprotein E4 Allele; Minimal Cognitive Impairment; Predictors of Disease Progression; Protective Factors

Effects of AD on Cognitive and Communicative FunctionsEarly Stage; Middle Stage; Late-Stage AD; Summary of Important Points; References; Unit 4: Assessment of Cognitive-Communicative Function in Minimal Cognitive Impairment and Alzheimer's Dementia; Role of the Speech-Language Pathologist; The Process of Assessment; Prior to Testing; Review Medical History; Secure a Quiet, Well-Lit Test Environment; Testing; Check Vision; Check Hearing; Check Literacy; Be Alert to Depression; Be Alert to Adverse Drug Effects on Performance; Use Appropriate Tests; Assessment of MCI Due to AD; Screening for MCI

Comprehensive Neuropsychological Approach to ScreeningAssessment of AD; Screening for AD; Comprehensive Assessment of AD; Summary of Important Points; References; Unit 5: Rationale for Therapy; Neuroplasticity; Memory Systems and Their Vulnerability to AD Pathology; Cognitive Reserve; Cognitive Stimulation Therapy Can Build Cognitive Reserve; Summary of Important Points; References; Unit 6: Cognitive Intervention and Minimal Cognitive Impairment; Different Forms of Cognitive Intervention Used in Individuals with MCI; Key Element 1: Base repetition focus on cognitive domains

Computer-Based TrainingKey Element 2: Provide direct training of strategies and functional skills.; Key Element 3: Empower clients with education regarding healthy aging and brain habits.; Key Element 4: Include opportunities for social engagement.; Conclusion; Summary of Important Points; References; Unit 7: Treatment: Direct Interventions; Definitions; Treatment Guidelines; Strategies for Successful Intervention; Facilitating Perception; Consider Span Capacity of Working Memory; Control of Task Complexity; Minimize Error Responses; Recognition Is Easier Than Recall

Use Retrieval Cues That Reflect Support Given at Encoding

Sommario/riassunto

This book succinctly presents critical information about the cognitive-communicative disorders associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). It includes cutting-edge information about MCI, a very early stage of Alzheimer's disease, and the role of speech-language pathologists (SLPs) in early identification and behavioral and/or pharmacologic treatments. Clinical essentials-definitions, assessments, and treatments-for MCI and AD are also covered.